TRIAMCINOLON MICRONIZED

Triamcinolone micronized improves absorption and topical efficacy with reduced particle size. Side effects include dryness, irritation, and potential systemic absorption effects. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 3ce734d373a5 Category: Tag:

Product Description


Mechanism of Action

TRIAMCINOLON MICRONIZED demonstrates a multilayer biochemical interaction architecture integrating highbandwidth signalling interference, catalyticdomain perturbation, mitochondrialnetwork recalibration, ionflux redistribution, cytoskeletal restructuring, membranepotential modulation and transcriptionfactor pathway realignment. Its molecular conformation enables docking to catalytic residues, allosteric nodes, transmembrane helices, nucleotidebinding pockets, redoxbuffer centres and polymeric scaffolding complexes, providing systemwide influence across metabolic, electrophysiological, structural and genomic domains.

At the signalling stratum, TRIAMCINOLON MICRONIZED may reshape phosphorylation landscapes, alter the propagation kinetics of ERK, MAPK, JNK and p38 pathways, modulate PI3KAKT survival gating, adjust Gprotein coupling efficiency, redistribute Ca²⁺ microdomains, influence IP/DAG signalling geometry, and redefine cAMPPKA amplitude. Mitochondrial effects include ETCcomplex rebalancing, ATP/ADP cycle remapping, ROSthreshold displacement, membranepotential polarity modulation and crossorganelle stress signalling.

HighPrecision

  • Kinomescale cascade interference mapping & catalyticpathway reconstruction
  • Highresolution docking, ligandmetastability tracking & conformationalflow modelling
  • UPR/ERstress, mitophagy and organelle crosstalk quantification
  • Multiomics regulatorynetwork reconstruction (RNAseq, metabolomics, phosphoproteomics, proteomics)
  • Cytoskeletal mechanics including actin/tubulin turnover and forcedistribution modelling
  • Cellfate simulations across apoptosis, necroptosis, ferroptosis & parthanatos pathways
  • AIenhanced SAR/QSAR optimisation engines for predictive compound modelling

Toxicodynamics & Cellular Hazard Spectrum

  • Acute ROS surge and antioxidantbuffer saturation
  • Mitochondrial fragmentation or ETCaxis collapse
  • Severe Na⁺/K⁺/Ca²⁺ ionhomeostasis destabilisation
  • Cytoskeletal depolymerisation & structuralintegrity failure
  • Membranetension breakdown & lipidbilayer thinning
  • Hyperactivation of inflammatory master regulators (NF-κB, STAT, IRF families)
  • Activation of multiple programmed-cell-death pathways
  • Epigenetic drift including methylation and acetylation instability

For expert not intended for biological or therapeutic exposure.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C21H27FO6

Molecular Weight

394.4 g/mol

CAS Number

124-94-7

Storage Condition

Store at 28°C

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

Synonym

Mycolog; RefChem:819685; 9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; Kenacort-AG; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-

IUPAC/Chemical Name

(11β)-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download